Oxalo Therapeutics
Cambridge, United States· Est.
Develops novel therapeutics for primary hyperoxaluria and other oxalate-related disorders.
Private Company
Total funding raised: $5.6M
About
Develops novel therapeutics for primary hyperoxaluria and other oxalate-related disorders.
RNA & Gene Therapy
Funding History
1Total raised:$5.6M
Seed$5.6M